These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37331996)

  • 41. YY1-regulated lncRNA SOCS2-AS1 suppresses HCC cell stemness and progression via miR-454-3p/CPEB1.
    Zhong F; Wang Y
    Biochem Biophys Res Commun; 2023 Oct; 679():98-109. PubMed ID: 37677983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma.
    Wei XC; Xia YR; Zhou P; Xue X; Ding S; Liu LJ; Zhu F
    World J Gastroenterol; 2021 Dec; 27(48):8302-8322. PubMed ID: 35068871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma.
    Li P; Song R; Yin F; Liu M; Liu H; Ma S; Jia X; Lu X; Zhong Y; Yu L; Li X; Li X
    Mol Ther; 2022 Jan; 30(1):431-447. PubMed ID: 34450251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The lncARSR/PTEN/Akt/nuclear factor-kappa B feedback regulatory loop contributes to doxorubicin resistance in hepatocellular carcinoma.
    Li Y; Li J; Chen H; Wang J; Jiang L; Tan X
    J Biochem Mol Toxicol; 2022 Sep; 36(9):e23119. PubMed ID: 35678308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nucleolar and spindle associated protein 1 promotes metastasis of cervical carcinoma cells by activating Wnt/β-catenin signaling.
    Li H; Zhang W; Yan M; Qiu J; Chen J; Sun X; Chen X; Song L; Zhang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):33. PubMed ID: 30678687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interferon-Gamma-Inducible Protein 16 Inhibits Hepatocellular Carcinoma via Interferon Regulatory Factor 3 on Chemosensitivity.
    Lin W; Zhao Z; Du W; Ni Z; Pan C; Fang P; Li J; ZhuGe L; Jin S
    Dig Dis Sci; 2024 Feb; 69(2):491-501. PubMed ID: 38170337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in hepatocellular carcinoma.
    Geng W; Ng KT; Sun CK; Yau WL; Liu XB; Cheng Q; Poon RT; Lo CM; Man K; Fan ST
    PLoS One; 2011; 6(11):e27362. PubMed ID: 22096562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
    Yang S; Wang XQ
    BMC Cancer; 2017 May; 17(1):344. PubMed ID: 28526069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma.
    Wang F; Xu C; Li G; Lv P; Gu J
    Exp Cell Res; 2021 Dec; 409(2):112910. PubMed ID: 34801560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
    Gong J; Du C; Sun N; Xiao X; Wu H
    J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
    Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
    Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analyzing Roles of NUSAP1 From Clinical, Molecular Mechanism and Immune Perspectives in Hepatocellular Carcinoma.
    Zhu W; Xu J; Chen Z; Jiang J
    Front Genet; 2021; 12():689159. PubMed ID: 34354737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cells.
    Wu X; Zhao B; Cheng Y; Yang Y; Huang C; Meng X; Wu B; Zhang L; Lv X; Li J
    Toxicol Appl Pharmacol; 2015 Oct; 288(1):74-83. PubMed ID: 26189965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis.
    Xu X; Liu Z; Zhou L; Xie H; Cheng J; Ling Q; Wang J; Guo H; Wei X; Zheng S
    J Exp Clin Cancer Res; 2015 Jan; 34(1):6. PubMed ID: 25609232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity.
    Teng K; Wei S; Zhang C; Chen J; Chen J; Xiao K; Liu J; Dai M; Guan X; Yun J; Xie D
    J Exp Clin Cancer Res; 2019 Jul; 38(1):329. PubMed ID: 31340839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.